Kovid 19 Haberleri


        
 
Haber:
Etiketler:
Yazarın adı:
Yazarın soyadı:


27 Mart 2022, Pazar, 16:02 Haber Kaynağı: Çeşitli Haber Siteleri
Doğu Ekspresi bilet fiyatları 2022 ne kadar? Doğu Ekspresi bilet alma nasıl yapılır?
Koronavirüs pandemisi nedeniyle seferlerine geçen yıl mart ayında ara verilen Turistik Doğu Ekspresi, aralık ayında yeniden yolculuğuna başladı. Peki, Doğu Ekspresi bilet fiyatları ne kadar? Doğu Ekspresi bilet alma nasıl yapılır? İşte detaylar..
https://www.cnnturk.com/yasam/dogu-ekspresi-bilet-fiyatlari-2022-ne-kadar-dogu-ekspresi-bilet-alma-nasil-yapilir

27 Mart 2022, Pazar, 14:02 Haber Kaynağı: Çeşitli Haber Siteleri
Türkiye'de Koronavirüs | 80 kişi daha hayatını kaybetti, 14 bin 933 yeni vaka tespit edildi

https://t24.com.tr/haber/turkiye-de-koronavirus-80-kisi-daha-hayatini-kaybetti-14-bin-933-yeni-vaka-tespit-edildi,1022457

27 Mart 2022, Pazar, 12:05 Haber Kaynağı: Çeşitli Haber Siteleri
Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022
This report describes effectiveness of mRNA COVID-19 vaccination in preventing COVID-19 associated invasive mechanical ventilation and death after receiving 2 or 3 vaccine doses.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=625714

27 Mart 2022, Pazar, 12:05 Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19-Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status - COVID-NET, 14 States, July 2021-January 2022
This report describes adult COVID-19 hospitalization rates by race/ethnicity during SARS-CoV-2 Delta and Omicron predominance.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=625715

27 Mart 2022, Pazar, 12:05 Haber Kaynağı: Çeşitli Haber Siteleri
Lessons Learned from Programmatic Gains in HIV Service Delivery During the COVID-19 Pandemic - 41 PEPFAR-Supported Countries, 2020
This report describes programmatic gains of HIV treatment during the pandemic.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=642931

27 Mart 2022, Pazar, 12:05 Haber Kaynağı: Çeşitli Haber Siteleri
Hospitalization of Infants and Children Aged 0-4 Years with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 2020-February 2022
This report describes COVID-19 hospitalization rates among infants and children aged 0-4 years, including during Omicron variant predominance.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=613117

27 Mart 2022, Pazar, 12:05 Haber Kaynağı: Çeşitli Haber Siteleri
The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines - United States, February 2022
This report describes the Advisory Committee on Immunization Practices' recommendation for use of the Moderna COVID-19 vaccine in adults.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=622515

27 Mart 2022, Pazar, 12:05 Haber Kaynağı: Çeşitli Haber Siteleri
Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022
This report describes vaccination with a primary series of the Pfizer-BioNTech mRNA COVID-19 vaccine as effective in protecting against Omicron infection among children and adolescents.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=603187

27 Mart 2022, Pazar, 12:05 Haber Kaynağı: Çeşitli Haber Siteleri
COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5-11 Years - United States, November 2021-January 2022
This report describes COVID-19 vaccine provider access and vaccination coverage among U.S. children aged 5-11 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=600326

27 Mart 2022, Pazar, 12:05 Haber Kaynağı: Çeşitli Haber Siteleri
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022
This report describes safety monitoring after a Pfizer-BioNTech booster vaccination among children and adolescents aged 12-17 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=575231